Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.88589 | 37 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.79697 | 35 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.7988 | 35 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.66582 | 32 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.74132 | 35 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.85638 | 34 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.83661 | 34 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.77203 | 34 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.76013 | 34 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.78447 | 35 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.8903 | 39 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.76924 | 35 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.78912 | 35 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.78922 | 35 |